The use of infliximab in South‐east Asian children with severe Crohn's disease

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations

“…[138][139][140][141][142][143][144][145][146][147][148][149] At this moment, the results of a multicentre RCT comparing two regimens of infliximab maintenance treatment (every eight weeks compared with every 12 weeks) are awaited.…”